Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

Marja-Riitta Taskinen, Chris J. Packard, Jan Boren

Research output: Contribution to journalReview ArticleScientificpeer-review

Original languageEnglish
Article number27
JournalCurrent atherosclerosis reports.
Volume21
Issue number8
Number of pages10
ISSN1523-3804
DOIs
Publication statusPublished - Aug 2019
MoE publication typeA2 Review article in a scientific journal

Fields of Science

  • ApoC-III
  • Lipoproteins
  • Triglycerides
  • Remnants
  • CVD
  • genetic variants
  • APOLIPOPROTEIN-C-III
  • OF-FUNCTION MUTATIONS
  • LOW-DENSITY LIPOPROTEINS
  • LIPID-BINDING
  • ATHEROGENIC LIPOPROTEINS
  • HYPOLIPIDEMIC ACTION
  • ENDOTHELIAL-CELLS
  • LDL SUBCLASSES
  • PLASMA-LIPIDS
  • CIII
  • 3121 Internal medicine

Cite this

@article{dbece8a72f0540e8a4e3551a9af26f80,
title = "Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD",
keywords = "ApoC-III, Lipoproteins, Triglycerides, Remnants, CVD, genetic variants, APOLIPOPROTEIN-C-III, OF-FUNCTION MUTATIONS, LOW-DENSITY LIPOPROTEINS, LIPID-BINDING, ATHEROGENIC LIPOPROTEINS, HYPOLIPIDEMIC ACTION, ENDOTHELIAL-CELLS, LDL SUBCLASSES, PLASMA-LIPIDS, CIII, 3121 Internal medicine",
author = "Marja-Riitta Taskinen and Packard, {Chris J.} and Jan Boren",
year = "2019",
month = "8",
doi = "10.1007/s11883-019-0791-9",
language = "English",
volume = "21",
journal = "Current atherosclerosis reports.",
issn = "1523-3804",
publisher = "CURRENT MEDICINE GROUP LLC",
number = "8",

}

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD. / Taskinen, Marja-Riitta; Packard, Chris J.; Boren, Jan.

In: Current atherosclerosis reports., Vol. 21, No. 8, 27, 08.2019.

Research output: Contribution to journalReview ArticleScientificpeer-review

TY - JOUR

T1 - Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

AU - Taskinen, Marja-Riitta

AU - Packard, Chris J.

AU - Boren, Jan

PY - 2019/8

Y1 - 2019/8

KW - ApoC-III

KW - Lipoproteins

KW - Triglycerides

KW - Remnants

KW - CVD

KW - genetic variants

KW - APOLIPOPROTEIN-C-III

KW - OF-FUNCTION MUTATIONS

KW - LOW-DENSITY LIPOPROTEINS

KW - LIPID-BINDING

KW - ATHEROGENIC LIPOPROTEINS

KW - HYPOLIPIDEMIC ACTION

KW - ENDOTHELIAL-CELLS

KW - LDL SUBCLASSES

KW - PLASMA-LIPIDS

KW - CIII

KW - 3121 Internal medicine

U2 - 10.1007/s11883-019-0791-9

DO - 10.1007/s11883-019-0791-9

M3 - Review Article

VL - 21

JO - Current atherosclerosis reports.

JF - Current atherosclerosis reports.

SN - 1523-3804

IS - 8

M1 - 27

ER -